Form 8-K - Current report:
SEC Accession No. 0001193125-23-108354
Filing Date
2023-04-20
Accepted
2023-04-20 16:26:03
Documents
14
Period of Report
2023-04-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d498999d8k.htm   iXBRL 8-K 36338
2 EX-10.1 d498999dex101.htm EX-10.1 104511
  Complete submission text file 0001193125-23-108354.txt   334681

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sclx-20230420.xsd EX-101.SCH 4469
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sclx-20230420_def.xml EX-101.DEF 13852
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sclx-20230420_lab.xml EX-101.LAB 23217
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sclx-20230420_pre.xml EX-101.PRE 14820
8 EXTRACTED XBRL INSTANCE DOCUMENT d498999d8k_htm.xml XML 5800
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 23833445
SIC: 2836 Biological Products, (No Diagnostic Substances)